7-121329771-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_057168.2(WNT16):c.300C>A(p.Thr100Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00702 in 1,608,816 control chromosomes in the GnomAD database, including 110 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 27 hom., cov: 34)
Exomes 𝑓: 0.0064 ( 83 hom. )
Consequence
WNT16
NM_057168.2 synonymous
NM_057168.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.818
Genes affected
WNT16 (HGNC:16267): (Wnt family member 16) The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene is a member of the WNT gene family. It contains two transcript variants diverging at the 5' termini. These two variants are proposed to be the products of separate promoters and not to be splice variants from a single promoter. They are differentially expressed in normal tissues, one of which (variant 2) is expressed at significant levels only in the pancreas, whereas another one (variant 1) is expressed more ubiquitously with highest levels in adult kidney, placenta, brain, heart, and spleen. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 7-121329771-C-A is Benign according to our data. Variant chr7-121329771-C-A is described in ClinVar as [Benign]. Clinvar id is 781654.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.818 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0128 (1948/152366) while in subpopulation AFR AF= 0.023 (958/41600). AF 95% confidence interval is 0.0218. There are 27 homozygotes in gnomad4. There are 968 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 27 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WNT16 | NM_057168.2 | c.300C>A | p.Thr100Thr | synonymous_variant | 2/4 | ENST00000222462.3 | NP_476509.1 | |
WNT16 | NM_016087.2 | c.270C>A | p.Thr90Thr | synonymous_variant | 2/4 | NP_057171.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WNT16 | ENST00000222462.3 | c.300C>A | p.Thr100Thr | synonymous_variant | 2/4 | 1 | NM_057168.2 | ENSP00000222462.2 | ||
WNT16 | ENST00000361301.6 | c.270C>A | p.Thr90Thr | synonymous_variant | 2/4 | 1 | ENSP00000355065.2 |
Frequencies
GnomAD3 genomes AF: 0.0128 AC: 1944AN: 152248Hom.: 27 Cov.: 34
GnomAD3 genomes
AF:
AC:
1944
AN:
152248
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00897 AC: 2194AN: 244660Hom.: 24 AF XY: 0.00854 AC XY: 1137AN XY: 133200
GnomAD3 exomes
AF:
AC:
2194
AN:
244660
Hom.:
AF XY:
AC XY:
1137
AN XY:
133200
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00641 AC: 9342AN: 1456450Hom.: 83 Cov.: 34 AF XY: 0.00645 AC XY: 4676AN XY: 724712
GnomAD4 exome
AF:
AC:
9342
AN:
1456450
Hom.:
Cov.:
34
AF XY:
AC XY:
4676
AN XY:
724712
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0128 AC: 1948AN: 152366Hom.: 27 Cov.: 34 AF XY: 0.0130 AC XY: 968AN XY: 74496
GnomAD4 genome
AF:
AC:
1948
AN:
152366
Hom.:
Cov.:
34
AF XY:
AC XY:
968
AN XY:
74496
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 08, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at